The wait is over: Lucentis has arrived in Europe

Article

Retinal specialists have a new therapy in their armoury: on January 24th 2007, the European Commission approved ranibizumab (Lucentis, Novartis) for the treatment of patients with wet age-related macular degeneration (AMD).

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
A newspaper sits folded so the heading "BUSINESS SECTION" is visible. Glasses rest on top of the paper. Image credit: ©GVictoria – stock.adobe.com

Industry updates from Floretina ICOOR 2024

Hattie Hayes
December 7th 2024
Article

The annual meeting brought fourth announcements and insights from companies in the retina care space

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

An older woman in glasses, smiling slightly, looks up and to the left. Image credit: ©Pavel Kubarkov – stock.adobe.com

New wet AMD therapeutics seek to improve visual outcomes beyond the current standard of care

Sean D. Adrean, MD, FAAO
December 5th 2024
Article

Breakthrough technologies are raising the ceiling for functional visual outcomes

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

An AI-generated image of Neuron Cells building a neural network. Image credit: ©Katynn – stock.adobe.com

Adapting our understanding of cerebral visual impairment

By Lynda Charters; Reviewed by Lotfi Merabet, OD, PhD
December 4th 2024
Article

The differential recruitment of the dorsal and ventral visual streams

A group of patients, including a diverse array of men, women and children, sit in a waiting room. Image credit: ©DC Studio – stock.adobe.com

Ethnic background has an impact on glaucoma outcomes

Lynda Charters; Reviewed by Atika Safitri, PhD
December 3rd 2024
Article

Gauging patient perceptions in an ethnically diverse UK cohort

© 2024 MJH Life Sciences

All rights reserved.